Abstract
‘New-Gen Vaccines’ are grabbing the attention of scientists as they are much suitable for an immune-compromised group of individuals as well as infants. The major drawbacks of these vaccines are lower immunogenicity and instability. The need for a convenient and safe adjuvant is still under exploration. On the other hand, thermal instability leads to the inactivation of the vaccine and becomes detrimental in many cases. Thus, there is a need to incorporate new kinds of excipients into vaccine formulation to enhance the potency/immunogenicity of vaccine antigens and also act as stabilizers. A limited or single excipient in providing the required dual-activity is vital to break the stereotypical usage of the well-entrenched adverse ingredients. In the proposed review, the efficiency of naturally occurring biocompatible carbohydrate polymers and osmolytes and their ‘dual-role’ is briefed. In addition, the information on the possible mechanisms of action of carbohydrate polymers in vaccines as adjuvants and stabilizers are also discussed.

Keywords: bio-molecules, carbohydrate polymers, osmolytes, mechanism of action, new-gen vaccines, vaccine excipients
Footnotes
Acknowledgment: We would like to acknowledge the support from the Defence Research and Development Organization (DRDO), Government of India, New Delhi, and the Indian Council of Medical Research (ICMR), Government of India, New Delhi.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Competing statement
The authors have no competing interests to declare that are relevant to the content of this article.
Authorship statement
Krubha Athirathinam: Conceptualization, Data curation, Writing-Original draft preparation and Writing-Reviewing and Editing. Selvasudha Nandakumar: Data curation and Visualization, Investigation. Ruckmani Kandasamy: Conceptualization, Visualization, Investigation, and Supervision.
References
- (1).World Health Organization. Projections of Mortality and Causes of Death, 2016 to 2060.
- (2).Moyle P M. Biotechnol. Adv. 2017;35:375. doi: 10.1016/j.biotechadv.2017.03.005. [DOI] [PubMed] [Google Scholar]
- (3).Perrie Y, Mohammed A R, Kirby D J, McNeil S E, Bramwell V W. Int. J. Pharm. 2008;364:272. doi: 10.1016/j.ijpharm.2008.04.036. [DOI] [PubMed] [Google Scholar]
- (4).Schmidt S T, Foged C, Korsholm K S, Rades T, Christensen D. Pharmaceutics. 2016;8:7. doi: 10.3390/pharmaceutics8010007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (5).S. Ausar, Hasija, Li, and Rahman, VDT, 11 (2013).
- (6).World Health Organization. Guidelines on Stability Evaluation of Vaccines, Expert Committee on Biological Standardization, Technical Report Series 57th Report, Geneva, 2006, No. 962, Annex 3.
- (7).Pollard E C. The Physics of Viruses. Burlington: Elsevier Science; 1953. pp. 103–121. [Google Scholar]
- (8).Peek L J, Martin T T, Elk Nation C, Pegram S A, Middaugh C R. J. Pharm. Sci. 2007;96:547. doi: 10.1002/jps.20762. [DOI] [PubMed] [Google Scholar]
- (9).Cherry J D. J. Infect. Dis. 1996;174:S259. doi: 10.1093/infdis/174.Supplement_3.S259. [DOI] [PubMed] [Google Scholar]
- (10).Apostolopoulos V. Expert Rev. Vaccines. 2010;9:551. doi: 10.1586/erv.10.54. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (11).Aguilar J C, Rodríguez E G. Vaccine. 2007;25:3752. doi: 10.1016/j.vaccine.2007.01.111. [DOI] [PubMed] [Google Scholar]
- (12).Crommelin D J A, Anchordoquy T J, Volkin D B, Jiskoot W, Mastrobattista E. J. Pharm. Sci. 2021;110:997. doi: 10.1016/j.xphs.2020.12.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (13).Zhang C, Maruggi G, Shan H, Li J. Front. Immunol. 2019;10:594. doi: 10.3389/fimmu.2019.00594. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (14).Domachowske J. In: Vaccines: A Clinical Overview and Practical Guide. 1st ed. Domachowske J, Suryadevar M, editors. Cham: Springer; 2021. pp. 49–76. [Google Scholar]
- (15).Cardoso F M C, Petrovajová D, Horňáková T. Acta Virol. 2017;61:231. doi: 10.4149/av_2017_301. [DOI] [PubMed] [Google Scholar]
- (16).Reddy S T, Swartz M A, Hubbell J A. Trends Immunol. 2006;27:573. doi: 10.1016/j.it.2006.10.005. [DOI] [PubMed] [Google Scholar]
- (17).Moyer T J, Zmolek A C, Irvine D J. J. Clin. Investig. 2016;126:799. doi: 10.1172/JCI81083. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (18).Shah R R, O’Hagan D T, Amiji M M, Brito L A. Nanomedicine. 2014;9:2671. doi: 10.2217/nnm.14.193. [DOI] [PubMed] [Google Scholar]
- (19).Passeri E, Villa C, Couette M, Itti E, Brugieres P, Cesaro P, Gherardi R K, Bachoud-Levi A-C, Authier F-J. J. Inorg. Biochem. 2011;105:1457. doi: 10.1016/j.jinorgbio.2011.08.006. [DOI] [PubMed] [Google Scholar]
- (20).Sakaguchi M, Yoshida M, Kuroda W, Harayama O, Matsunaga Y, Inouye S. Vaccine. 1997;15:121. doi: 10.1016/S0264-410X(96)00170-3. [DOI] [PubMed] [Google Scholar]
- (21).Guo S, Fu D, Utupova A, Sun D, Zhou M, Jin Z, Zhao K. Nanotechnol. Rev. 2019;8:143. doi: 10.1515/ntrev-2019-0014. [DOI] [Google Scholar]
- (22).Garcia-Vello P, Speciale I, Chiodo F, Molinaro A, De Castro C. Drug Discov. Today Technol. 2020;35:57. doi: 10.1016/j.ddtec.2020.09.005. [DOI] [PubMed] [Google Scholar]
- (23).Pifferi C, Fuentes R, Fernández-Tejada A. Nat. Rev. Chem. 2021;5:197. doi: 10.1038/s41570-020-00244-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (24).Franck C O, Fanslau L, Bistrovic Popov A, Tyagi P, Fruk L. Angew. Chem. Int. Ed. 2021;60:13225. doi: 10.1002/anie.202010282. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (25).Ma P L, Lavertu M, Winnik F M, Buschmann M D. Biomacromolecules. 2009;10:1490. doi: 10.1021/bm900097s. [DOI] [PubMed] [Google Scholar]
- (26).Ma L, Liu C. Colloids Surf. B: Biointerfaces. 2010;75:448. doi: 10.1016/j.colsurfb.2009.09.018. [DOI] [PubMed] [Google Scholar]
- (27).Boroumand H, Badie F, Mazaheri S, Seyedi Z S, Nahand J S, Nejati M, Baghi H B, Abbasi-Kolli M, Badehnoosh B, Ghandali M, Hamblin M R, Mirzaei H. Front. Cell. Infect. Microbiol. 2021;11:175. doi: 10.3389/fcimb.2021.643953. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (28).Wang Z-B, Shan P, Li S-Z, Zhou Y, Deng X, Li J-L, Zhang Y, Gao J-S, Xu J. RSC Adv. 2016;6:96785. doi: 10.1039/C6RA14419E. [DOI] [Google Scholar]
- (29).El-Sissi A F, Mohamed F H, Danial N M, Gaballah A Q, Ali K A. 3 Biotech. 2020;10:1. doi: 10.1007/s13205-020-2076-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (30).Yu S, Hao S, Sun B, Zhao D, Yan X, Jin Z, Zhao K. CMC. 2020;27:4932. doi: 10.2174/0929867326666190227192527. [DOI] [PubMed] [Google Scholar]
- (31).Chuang C-C, Tsai M-H, Yen H, Shyu H-F, Cheng K, Chen X, Chen C, Young J, Kau J-H. Carbohydr. Polym. 2020;229:115403. doi: 10.1016/j.carbpol.2019.115403. [DOI] [PubMed] [Google Scholar]
- (32).Ghendon Y, Markushin S, Vasiliev Y, Akopova I, Koptiaeva I, Krivtsov G, Borisova O, Ahmatova N, Kurbatova E, Mazurina S, Gervazieva V. J. Med. Virol. 2009;81:494. doi: 10.1002/jmv.21415. [DOI] [PubMed] [Google Scholar]
- (33).Harde H, Agrawal A K, Jain S. Pharm. Res. 2014;32:122. doi: 10.1007/s11095-014-1449-5. [DOI] [PubMed] [Google Scholar]
- (34).Zhang J, Sun H, Gao C, Wang Y, Cheng X, Yang Y, Gou Q, Lei L, Chen Y, Wang X, Zou Q, Gu J. J. Nanobiotechnol. 2021;19:1. doi: 10.1186/s12951-020-00755-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (35).Malik A, Gupta M, Gupta V, Gogoi H, Bhatnagar R. IJN. 2018;13:7959. doi: 10.2147/IJN.S165876. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (36).Raghuwanshi D, Mishra V, Das D, Kaur K, Suresh M R. Mol. Pharmaceutics. 2012;9:946. doi: 10.1021/mp200553x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (37).Khatri K, Goyal A K, Gupta P N, Mishra N, Vyas S P. Int. J. Pharm. 2008;354:235. doi: 10.1016/j.ijpharm.2007.11.027. [DOI] [PubMed] [Google Scholar]
- (38).Ghalavand M, Saadati M, Salimian J, Abbasi E, Hosseinzadeh G, Gouvarchin Ghaleh H E, Ahmadi A. Clin. Exp. Vaccine Res. 2021;10:24. doi: 10.7774/cevr.2021.10.1.24. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (39).van der Maaden K, Sekerdag E, Schipper P, Kersten G, Jiskoot W, Bouwstra J. Langmuir. 2015;31:8654. doi: 10.1021/acs.langmuir.5b01262. [DOI] [PubMed] [Google Scholar]
- (40).Verheul R J, Slütter B, Bal S M, Bouwstra J A, Jiskoot W, Hennink W E. J. Control. Release. 2011;156:46. doi: 10.1016/j.jconrel.2011.07.014. [DOI] [PubMed] [Google Scholar]
- (41).Ishii-Mizuno Y, Umeki Y, Onuki Y, Watanabe H, Takahashi Y, Takakura Y, Nishikawa M. Int. J. Pharm. 2017;516:392. doi: 10.1016/j.ijpharm.2016.11.048. [DOI] [PubMed] [Google Scholar]
- (42).Xing L, Fan Y-T, Zhou T-J, Gong J-H, Cui L-H, Cho K-H, Choi Y-J, Jiang H-L, Cho C-S. Molecules. 2018;23:229. doi: 10.3390/molecules23020229. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (43).Robla S, Prasanna M, Varela-Calviño R, Grandjean C, Csaba N. Drug Deliv. Transl. Res. 2021;11:581. doi: 10.1007/s13346-021-00928-3. [DOI] [PubMed] [Google Scholar]
- (44).Zuo Z, Zou Y, Li Q, Guo Y, Zhang T, Wu J, He C, Eko F O. Sci. Rep. 2021;11:1. doi: 10.1038/s41598-020-79139-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (45).Rigby P G. Nature. 1969;221:968. doi: 10.1038/221968a0. [DOI] [PubMed] [Google Scholar]
- (46).Houston W E, Crabbs C L, Kremer R J, Springer J W. Infect. Immun. 1976;13:1559. doi: 10.1128/iai.13.6.1559-1562.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (47).Kramer R M, Zeng Y, Sahni N, Kueltzo L A, Schwartz R M, Srivastava I K, Crane L, Joshi S B, Volkin D B, Russell Middaugh C. J. Pharm. Sci. 2013;102:4305. doi: 10.1002/jps.23749. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (48).Alfano C, Sanfelice D, Martin S R, Pastore A, Temussi P A. Nat. Commun. 2017;8:1. doi: 10.1038/ncomms15428. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (49).Joshy K S, George A, Snigdha S, Joseph B, Kalarikkal N, Pothen L A, Thomas S. Mater. Sci. Eng. C. 2018;93:864. doi: 10.1016/j.msec.2018.08.015. [DOI] [PubMed] [Google Scholar]
- (50).Mogoşanu G D, Grumezescu A M, Bejenaru C, Bejenaru L E. Int. J. Pharm. 2016;510:419. doi: 10.1016/j.ijpharm.2016.03.014. [DOI] [PubMed] [Google Scholar]
- (51).Diwan M, Khar R K, Talwar G P. Vaccine. 2001;19:3853. doi: 10.1016/S0264-410X(01)00140-2. [DOI] [PubMed] [Google Scholar]
- (52).Mohaghegh M, Tafaghodi M. Pharm. Dev. Technol. 2010;16:36. doi: 10.3109/10837450903479962. [DOI] [PubMed] [Google Scholar]
- (53).Kanthamneni N, Sharma S, Meenach S A, Billet B, Zhao J-C, Bachelder E M, Ainslie K M. Int. J. Pharm. 2012;431:101. doi: 10.1016/j.ijpharm.2012.04.043. [DOI] [PubMed] [Google Scholar]
- (54).Wang S, Fontana F, Shahbazi M-A, Santos H A. Chem. Commun. 2021;57:4212. doi: 10.1039/D1CC00811K. [DOI] [PubMed] [Google Scholar]
- (55).Stiepel R T, Batty C J, MacRaild C A, Norton R S, Bachelder E, Ainslie K M. Int. J. Pharm. 2021;593:120168. doi: 10.1016/j.ijpharm.2020.120168. [DOI] [PubMed] [Google Scholar]
- (56).Schully K L, Bell M G, Prouty A M, Gallovic M D, Gautam S, Peine K J, Sharma S, Bachelder E M, Pesce J T, Elberson M A, Ainslie K M, Keane-Myers A. Int. J. Pharm. 2015;495:849. doi: 10.1016/j.ijpharm.2015.09.059. [DOI] [PubMed] [Google Scholar]
- (57).Saluja V, Amorij J-P, Kapteyn J C, de Boer A H, Frijlink H W, Hinrichs W L J. J. Control. Release. 2010;144:127. doi: 10.1016/j.jconrel.2010.02.025. [DOI] [PubMed] [Google Scholar]
- (58).Tonnis W F, Mensink M A, de Jager A, van der Voort Maarschalk K, Frijlink H W, Hinrichs W L J. Mol. Pharm. 2015;12:684. doi: 10.1021/mp500423z. [DOI] [PubMed] [Google Scholar]
- (59).Amorij J-P, Saluja V, Petersen A H, Hinrichs W L J, Huckriede A, Frijlink H W. Vaccine. 2007;25:8707. doi: 10.1016/j.vaccine.2007.10.035. [DOI] [PubMed] [Google Scholar]
- (60).Kumar S, Tummala H. Mol. Pharm. 2013;10:1845. doi: 10.1021/mp3006374. [DOI] [PubMed] [Google Scholar]
- (61).Tonnis W F, Amorij J-P, Vreeman M A, Frijlink H W, Kersten G F, Hinrichs W L J. Eur. J. Pharm. Sci. 2014;55:36. doi: 10.1016/j.ejps.2014.01.005. [DOI] [PubMed] [Google Scholar]
- (62).Cooper P D, Petrovsky N. Glycobiology. 2010;21:595. doi: 10.1093/glycob/cwq201. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (63).Ferrell K C, Stewart E L, Counoupas C, Ashhurst T M, Britton W J, Petrovsky N, Triccas J A. Mucosal Immunol. 2021;14:762. doi: 10.1038/s41385-021-00379-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (64).Gordon D, Kelley P, Heinzel S, Cooper P, Petrovsky N. Vaccine. 2014;32:6469. doi: 10.1016/j.vaccine.2014.09.034. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (65).Nolan T, Richmond P C, Formica N T, Höschler K, Skeljo M V, Stoney T, McVernon J, Hartel G, Sawlwin D C, Bennet J, Ryan D, Basser R L, Zambon M C. Vaccine. 2008;26:6383. doi: 10.1016/j.vaccine.2008.08.046. [DOI] [PubMed] [Google Scholar]
- (66).Cooper P D, Steele E J. Immunol. Cell Biol. 1988;66:345. doi: 10.1038/icb.1988.45. [DOI] [PubMed] [Google Scholar]
- (67).Moghimi S M, Hunter A C. Trends Biotechnol. 2000;18:412. doi: 10.1016/S0167-7799(00)01485-2. [DOI] [PubMed] [Google Scholar]
- (68).Spitzer N. Vaccine. 1999;17:1298. doi: 10.1016/S0264-410X(98)00363-6. [DOI] [PubMed] [Google Scholar]
- (69).Greenland J R, Letvin N L. Vaccine. 2007;25:3731. doi: 10.1016/j.vaccine.2007.01.120. [DOI] [PubMed] [Google Scholar]
- (70).Tobío M, Nolley J, Guo Y, McIver J, Alonso M J. Pharm. Res. 1999;16:682. doi: 10.1023/A:1018820507379. [DOI] [PubMed] [Google Scholar]
- (71).Leroux-Roels G. Vaccine. 2010;28:C25. doi: 10.1016/j.vaccine.2010.07.021. [DOI] [PubMed] [Google Scholar]
- (72).Bolen D W, Baskakov I V. J. Mol. Biol. 2001;310:955. doi: 10.1006/jmbi.2001.4819. [DOI] [PubMed] [Google Scholar]
- (73).Kumar T, Yadav M, Singh L R. CPD. 2016;22:3050. doi: 10.2174/1381612822666160307150059. [DOI] [PubMed] [Google Scholar]
- (74).Quan F-S, Kim Y-C, Yoo D-G, Compans R W, Prausnitz M R, Kang S-M. PLoS ONE. 2009;4:e7152. doi: 10.1371/journal.pone.0007152. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (75).Flood A, Estrada M, McAdams D, Ji Y, Chen D. PLoS ONE. 2016;11:e0164692. doi: 10.1371/journal.pone.0164692. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (76).Hassett K J, Meinerz N M, Semmelmann F, Cousins M C, Garcea R L, Randolph T W. Eur. J. Pharm. Biopharm. 2015;94:220. doi: 10.1016/j.ejpb.2015.05.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (77).A. Lynch, A. E. Meyers, A.-L. Williamson, and E. P. Rybicki, Virol. J., 9, (2012). [DOI] [PMC free article] [PubMed]
- (78).Leung V, Mapletoft J, Zhang A, Lee A, Vahedi F, Chew M, Szewczyk A, Jahanshahi-Anbuhi S, Ang J, Cowbrough B, Miller M S, Ashkar A, Filipe C D M. Sci. Rep. 2019;9:1. doi: 10.1038/s41598-018-37186-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (79).Correia R, Meneses L, Richheimer C, Alves P M, Carrondo M J T, Duarte A R C, Paiva A, Roldão A. Vaccine. 2021;39:3279. doi: 10.1016/j.vaccine.2021.04.033. [DOI] [PubMed] [Google Scholar]
- (80).Noel Masihi K, Lange W, Brehmer W, Ribi E. Int. J. Immuno-Pharmacol. 1986;8:339. doi: 10.1016/0192-0561(86)90116-5. [DOI] [PubMed] [Google Scholar]
- (81).Kim Y-C, Quan F-S, Compans R W, Kang S-M, Prausnitz M R. J. Control. Release. 2010;142:187. doi: 10.1016/j.jconrel.2009.10.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (82).Hasan T, Kumari K, Devi S C, Handa J, Rehman T, Ansari N A, Singh L R. Hum. Vaccines Immunother. 2018;15:514. doi: 10.1080/21645515.2018.1526585. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (83).Ishizaka S, Yoshikawa M, Kitagami K, Tsujii T. Vaccine. 1990;8:337. doi: 10.1016/0264-410X(90)90091-Y. [DOI] [PubMed] [Google Scholar]
- (84).Ishizaka S, Kuriyama S, Kikuchi E, Nishimura K, Tsujii T. J. Hepatol. 1990;11:326. doi: 10.1016/0168-8278(90)90216-E. [DOI] [PubMed] [Google Scholar]
